Date: 3.8.2020
Further expanding the scope of its international competitions designed to solve global problems through technology, XPrize has launched a contest to develop new and improved testing methods for COVID-19. With millions of dollars of prize money up for grabs, the contest aims to usher in new technologies that allow for cheap, wide-spread testing with rapid results.
The XPrize Rapid Covid Testing competition is being held in collaboration with OpenCovidScreen, a non-profit organization working to improve testing technologies for the virus. The way these two see it, current testing for COVID-19 is expensive, invasive and slow, and is incompatible with the idea of reopening sections of society while the virus continues to circulate.
The competition involves US$5 million in prize money and is open to entrants all around the world. The winning teams will demonstrate COVID-19 tests that are “radically affordable” compared to today’s, and must be able to produce results from a sample within 12 hours. The sampling methods must be minimally invasive and cost less than $15 per test.
The winning teams will also need to deploy their technologies and carry out a minimum of 500 tests per week at a live testing site within 60 days. Registrations are open until August 31,2020, with the competition scheduled to take six months.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Environmetal biotechnology - Information about environmetal biotechnology at Wikipedia
Cancer cells - Czech Scientists are Working to Find the Achilles‘ Heel of Cancer Cells
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants
More than 30 new species of bacteria discovered in patient samples